D.A. DAVIDSON & CO. - GW PHARMACEUTICALS PLC ownership

GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 280 filers reported holding GW PHARMACEUTICALS PLC in Q4 2020. The put-call ratio across all filers is 1.24 and the average weighting 0.1%.

Quarter-by-quarter ownership
D.A. DAVIDSON & CO. ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q3 2020$225,000
-44.3%
2,310
-29.8%
0.00%
-50.0%
Q2 2020$404,000
-12.2%
3,292
-37.3%
0.01%
-11.1%
Q1 2020$460,000
-20.0%
5,250
-4.5%
0.01%0.0%
Q4 2019$575,000
+24.2%
5,496
+36.6%
0.01%
+12.5%
Q3 2019$463,000
-25.7%
4,024
+11.4%
0.01%
-33.3%
Q2 2019$623,000
+5.8%
3,611
+3.3%
0.01%
+20.0%
Q1 2019$589,000
+89.4%
3,494
+94.0%
0.01%
+66.7%
Q3 2018$311,000
+3010.0%
1,801
+1701.0%
0.01%
Q2 2017$10,000
-16.7%
1000.0%0.00%
Q1 2017$12,000
+9.1%
1000.0%0.00%
Q4 2016$11,000
-15.4%
1000.0%0.00%
Q3 2016$13,0000.0%100
-32.4%
0.00%
Q2 2016$13,000
+85.7%
148
+48.0%
0.00%
Q1 2016$7,000
+16.7%
1000.0%0.00%
Q4 2015$6,000
-33.3%
1000.0%0.00%
Q3 2015$9,000
-25.0%
1000.0%0.00%
Q2 2015$12,000
+33.3%
1000.0%0.00%
Q1 2015$9,0001000.00%
Other shareholders
GW PHARMACEUTICALS PLC shareholders Q4 2020
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 390,000$45,010,0007.31%
Copernicus Capital Management, LLC 2,788$322,0005.02%
Integral Health Asset Management, LLC 72,500$8,367,0002.49%
Parkman Healthcare Partners LLC 81,573$9,414,0002.41%
AdvisorShares Investments LLC 66,317$7,654,0001.78%
Tri Locum Partners LP 40,159$4,635,0001.68%
ETF MANAGERS GROUP, LLC 621,361$71,711,0001.57%
Redmile Group, LLC 815,681$94,138,0001.14%
Redwood Investments, LLC 108,999$12,580,0001.07%
ROOSEVELT INVESTMENT GROUP LLC 127,885$14,759,0001.05%
View complete list of GW PHARMACEUTICALS PLC shareholders